PATENT CLAIM ANALYSIS

Application Number: 16046047
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["435", "006100"]

Abstract:
The present invention relates to methods for detecting, enriching, and analyzing rare cells that are present in the blood, e.g. fetal cells. The invention further features methods of analyzing rare cell(s) to determine the presence of an abnormality, disease or condition in a subject, e.g. a fetus by analyzing a cellular sample from the subject.

Claim (Index 78):
The method of  claim 73 , further comprising labeling the fetal and maternal genomic nucleic acids with biotin and immobilizing the biotin-labeled genomic nucleic acids to a solid support prior to step b.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 95.0
- Lexical Diversity: 1.55814
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14705239', '11763245', '13835926', '13837974', '12230628']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7767848862865088
- 35 USC 102 Novelty (BERT): 0.6229331103195214
- Combined Prediction Score: 0.76139970868981
- Mean Citation Score: 537.6750679999999
- Max Citation Score: 631.3265
- Similarity Product: 390.4101109718084

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test